ATLASChampions Oncology (CSBR) earnings date: Dec 21, 2026
Champions Oncology (CSBR) reports earnings for the quarter ended Oct 31, 2026 on Mon, Dec 21, 2026.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on CSBR
| Last price | $4.81 (0.0%) |
|---|---|
| Normal 1-day range (±1σ) | ±2.4% |
| Earnings beat history | Beat the EPS estimate in 1 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Champions Oncology stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Champions Oncology reports on Dec 21, 2026. One email the day before, with ATLAS’s read on Champions Oncology. You can switch it off at any time.
Alert me before CSBR reportsFree to start. Creating an account takes under a minute.
CSBR earnings at a glance
| Next report (confirmed) | Mon, Dec 21, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Oct 31, 2026 |
| Last report | Sep 10, 2026 · Miss |
| Beat rate (last 4 reports) | 1 of 4 (25%) |
| Average EPS surprise | -46.8% |
| Average move around a report | ±0.6% (last 3) |
| Sector | Healthcare · Biotechnology |
Champions Oncology earnings history: last 4 reports
Champions Oncology last reported on Sep 10, 2026: EPS of -$0.03 against an estimate of -$0.01 (-200.0% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Sep 10, 2026 | -$0.01 | -$0.03 | -200.0% | Miss | – |
| May 8, 2026 | $0.11 | $0.13 | +18.2% | Beat | +0.3% |
| Feb 23, 2026 | $0.42 | $0.40 | -4.8% | Miss | -0.3% |
| Nov 20, 2025 | $14.83 | $14.73 | -0.7% | In line | -1.2% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for CSBR
See the fair value, the probability range and the earnings history of Champions Oncology on its ATLAS page.
Champions Oncology (CSBR) stock analysisPlans from €3.99 a month.
Champions Oncology earnings: frequently asked questions
When does Champions Oncology (CSBR) report earnings?
Champions Oncology is scheduled to report on Monday, December 21, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
How often does CSBR beat earnings estimates?
Of its last 4 reports with a recorded result, Champions Oncology beat the EPS estimate 1 times; the average surprise was -46.8%. Past results do not predict the next one.
How much does CSBR move around earnings?
Over its last 3 reports the stock moved an average of 0.6% (absolute, from the close before the report day to the close after it), and finished higher 1 of 3 times.
Did Champions Oncology beat earnings estimates last quarter?
Champions Oncology last reported on Sep 10, 2026: EPS of -$0.03 against an estimate of -$0.01 (-200.0% surprise), a miss.
How much does CSBR usually move in a day?
On a normal trading day the ATLAS model puts CSBR’s one-day range at about ±2.4%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Mon, Dec 21, 2026
Educational information, not investment advice. Disclaimer